Recombinant human immunodeficiency virus 1 (HIV-1) protease, purified from a bacterial expression system, processed a recombinant form of its natural substrate, Pr55sag, into protein fragments that possess molecular weights commensurate with those of the virion gag proteins. Molecular weights of the protease obtained under denaturing and nondenaturing conditions (11,000 and 22,000, respectively) and chemical crosslinking studies were consistent with a dimeric structure for the active enzyme. The protease appropriately cleaved the nonapeptide Ac-Arg-Ala-Ser-Gln-Asn-Tyr-ProVal-Val-NH2 between the tyrosine and proline residues. HIV-1 protease was sensitive to inactivators of the aspartic proteases. The aspartic protease inactivator 1,2-epoxy-3-(4-nitrophenoxy)propane produced irreversible, time-dependent inactivation of the protease. The pH-dependent kinetics of this inactivator were consistent with the requirement of an unprotonated carboxyl group in the active site of the enzyme, suggesting that HIV-1 protease is also an aspartic protease.
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The genome of the type 1 human immunodeficiency virus (HIV-1) possesses the same 5'-gag-pol-env-3' organization as other retroviruses (1) (2) (3) (4) . The initial translation product of the HIV-1 gag gene is a 55-kDa precursor (Pr55M) that is subsequently processed into the gag proteins p17, p24, and p15 (p7/p6) during virion formation (2, 5) . The pol coding region, which overlaps gag in the -1 reading frame, is expressed as a fusion product of gag and pol by a translational frameshift upstream of the gag termination codon (6) . This gag-pol precursor (Pr16099P0l) is processed into the gag proteins, a protease, a reverse transcriptase, and an endonuclease. In all retroviruses, the gag and gag-pol precursors are cleaved into their mature protein products by a specific, virally encoded protease (7). One conserved peptide sequence recognized by retroviral proteases (8) and found repeatedly within the translated HIV-1 gag and pol genes is (Ser/Thr)-Xaa-Yaa-(Tyr/ Phe)-Pro-Zaa. Proteolysis ofthis sequence occurs between the aromatic amino acid and proline residues. Retroviruses made deficient in protease by deletion or point mutation are characterized by immature morphology and infection incompetence (9-11), suggesting that the retroviral proteases are essential for the development of infectious virus. Accordingly, inhibition of the active protease within infectious HIV or HIV-infected cells represents a new therapeutic opportunity for the treatment of acquired immunodeficiency syndrome (AIDS) and related disorders.
Protein sequence homologies suggest that the retroviral proteases belong to the family of aspartic proteases (12) . The retroviral proteases that have been purified and sequenced to date (13) (14) (15) (16) (10, (19) (20) (21) (22) have subcloned and expressed HIV-1 protease in Escherichia coli. Our studies demonstrated that (i) the protease activity resides entirely within the pol reading frame of HIV-1; (ii) the recombinant enzyme can apparently catalyze its own cleavage from a fusion protein precursor in vivo; (iii) the N terminus of the recombinant protease, Pro-Gln-Ile-Thr-Leu, is consistent with processing at the proteolytic consensus sequence Ser-Phe-AsnPhe*Pro-Gln [residues [65] [66] [67] [68] [69] [70] and methods for expression of recombinant HIV-1 protease and Pr55sag in E. coli have been described (18). HIV-1 protease was obtained from the PRO4 expression vector in E. coli strain AR58 by heat induction (24) or AR120 by nalidixic acid induction (25) . Under these conditions, rapid autoproteolysis of the expressed 25-kDa fusion-protein precursor resulted in the production of a small quantity of a soluble 11-kDa protein (denatured molecular mass) that reacted with a polyclonal antibody raised against the PRO4 product (18).
The purification of active protease from such bacterial cell lysates will be described in detail elsewhere (J.E.S., unpubAbbreviations: Ac-RASQNYPVV-NH2, Ac-Arg-Ala-Ser-Gln-AsnTyr-Pro-Val-Val-NH2; DMS, dimethyl suberimidate; EPNP, 1,2-epoxy-(4-nitrophenoxy)propane; HIV-1, human immunodeficiency virus 1. tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. lished data). In brief, packed E. coli cells containing the induced PRO4 plasmid were lysed by sonication, and the protease was precipitated from the lysis supernatant with ammonium sulfate. Precipitated proteins were resuspended and subjected to size-exclusion HPLC on a TSK G2000 SW column. Purified HIV-1 protease was stored indefinitely at -200C in 20 mM Tris HCI, pH 7.5/1 mM dithiothreitol/1 mM EDTA/200 mM NaCl/40% (vol/vol) glycerol at protein concentrations of 1-200 gg/ml.
Peptidolytic Assay of HIV-1 Protease Activity and Proteolysis of p55. HIV-1 protease activity in crude extracts and in purified preparations was measured by quantification of the peptidolysis products of the synthetic nonapeptide Ac-ArgAla-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 (Ac-RASQNYPVV-NH2). A typical peptidolytic assay contained 2-3 mM Ac-RASQNYPVV-NH2 and crude PRO4 extract or 8-250 ng of purified protease in 10 ptl of 50 mM Mes, pH 6.0/1 mM EDTA/0.2 M NaCI/1 mM dithiothreitol/0.1% Triton X-100 (MENDT buffer) at 370C. Reaction was quenched after 2-15 min with an equal volume of 0.6 M trichloroacetic acid, and peptidolytic products were analyzed by reverse-phase HPLC [Beckman Ultrasphere ODS column (4.5 mm x 25 cm); mobile phase, 5-20% acetonitrile (15 min) and 20% acetonitrile (5 min) in 0.1% trifluoroacetic acid at 1.5 ml/min; detection at 220 nm]. Proteolysis of p55 by purified fractions of HIV-1 protease was performed at 37°C in 10-/Al reaction mixtures containing 1.0 ,g of p55 and 30-210 ng of the enzyme in MENDT buffer. Reaction was quenched after 30-60 min by boiling the reaction mixtures in NaDodSO4/PAGE sample buffer. Samples were then subjected to NaDodSO4/ PAGE in 15% polyacrylamide minigels (4.5 cm x 8 cm x 1 mm) and proteins were visualized by silver staining.
Analytical Gel Filtration and Glycerol Density Gradient
Ultracentrifugation of HIV-1 Protease. Crude PRO4 extract (0.75 ml, 32 mg of protein) was chromatographed on a column (2.5 cm x 20 cm) of Sephacryl S-200 superfine (Pharmacia) equilibrated with 50 mM Tris-HCl, pH 7.0/1 mM EDTA/0.1 M NaCl/1 mM dithiothreitol/0.15% Triton X-100 (TENDT buffer) at a flow rate of 8 ml/hr (4°C). Protease activity in column fractions was determined by the peptidolytic assay. Ultracentrifugation of HIV-1 protease was performed in a glycerol density gradient. Purified protease (5 ,g, 0.24 ml) was layered onto a 4-ml 17-35% (vol/vol) glycerol density gradient (26) prepared in TENDT buffer (pH 7.0; with and without 0.15% Triton X-100). An identical sample contained 0.05 mg of each of the protein standards cytochrome c, chymotrypsinogen A, and ovalbumin. Samples were ultracentrifuged for 40 hr (40C) at 55,000 rpm in a Beckman SW60 rotor. Aliquots (0.2 ml) were assayed for standard proteins by spectral analysis (280 nm, 410 nm) and by NaDodSO4/ PAGE, and HIV-1 protease activity was assayed by the peptidolytic assay as described above.
Crosslinking ofHIV-1 Protease. Purified HIV-1 protease was crosslinked with dimethyl suberimidate (DMS) according to the method of Davies and Stark (27) . Reaction mixtures containing 0.2 M bicine (pH 8.5) and purified HIV-1 protease (1.4-69 ,ug/ml) with or without 1.7-8.7 mM DMS were incubated at room temperature for 5-8 hr, then denatured with NaDodSO4/PAGE sample buffer and subjected to NaDod-S04/PAGE in 15% polyacrylamide minigels as described above. The protein bands were electrophoretically transferred onto nitrocellulose paper, and the resulting blot was probed with a polyclonal antibody (18) raised against the PRO4 product. Protein-antibody complexes were visualized by autoradiography following treatment with 1251I-labeled protein A. Inactivation Studies of HIV-1 Protease. Commercially available protease inactivators (0.1 and 10 mM) were preincubated with 0.7 ,4g purified protease for 1 hr at 370C in 10 gl of 50 mM Mes, pH 6/0.2 M NaCl/0.1% Triton X-100. Dimethyl sulfoxide at 5% final concentration was used for water-insoluble compounds. Aliquots of 10 Al were then removed and assayed for protease activity as described above in a 20-/l total volume containing 2 mM Ac-RASQNYPVV-NH2 in MENDT buffer (pH 6.0 purified protease (30-340 ng) effected progressive proteolysis of p55 (51 kDa) to 41-kDa, 32-kDa, 24-kDa, and 21-kDa protein fragments in 1 hr. The sizes of these protein products are consistent with cleavage at the p24-p15 junction (41 kDa), the p17-p24junction (32 kDa), or at bothjunctions to form the p245ag (24 kDa) and the fusion protein pl7gag (21 kDa) (the p15 product, predicted to be an 8-kDa protein, is not observed). Upon extended incubation times, the p55 and 41-kDa proteins were completely absent and the 32-kDa protein was diminished but no additional digestion of the 24-kDa and 21-kDa proteins was apparent. These findings suggest that the recombinant HIV-1 protease properly processes a recombinant form of its natural substrate, Pr55sag. The highly purified recombinant HIV-1 protease (Fig. 1 , lanes 6 and 7) appeared as a single protein band of 11 kDa (>90% of total protein by densitometric analysis). The autoprocessing in E. coli of a 25-kDa precursor construct of the HIV-1 pol coding region (PRO4) to an active protease of 11 kDa (18) is consistent with the premise that the HIV-1 protease comprises a 99-residue sequence (codons 69-167 in the pol reading frame; numbering as in ref . 1) between two consensus cleavage sequences [(Thr/Ser)-Xaa-Yaa-Phe*Pro)] at both the amino and carboxyl termini.
In addition to the protein substrate, the protease hydrolyzes the nonapeptide Ac-RASQNYPVV-NH2, which bears a sequence similar to the known p17-p24 junction in Pr55sag (2). Analysis of the peptidolytic fragments of Ac-RASQNYPVV-NH2 by reverse-phase HPLC (Fig. 2) provided a routine, quantitative assay for preliminary studies of the enzymological properties of HIV-1 protease. Carboxyl-terminal sequence analysis of a preparative sample of the peptide eluted at 10 min was consistent with the sequence Xaa-Ala-Ser-GlnAsn-Tyr (J.E.S., unpublished data), demonstrating that as expected, HIV-1 protease cleaved the nonapeptide between the tyrosine and proline residues. Under reaction conditions identical to those used with the protease, neither p55 nor Ac-RASQNYPVV-NH2 gave the observed cleavage patterns upon incubation with identically prepared bacterial extracts containing a pAS plasmid that lacked the PRO4 insert. These results make unlikely the possibility that the observed proteolysis and peptidolysis by material from PRO4-containing bacteria were due to bacterial proteases.
The time course of the peptidolytic activity obtained from integration of the Ac-RASQNY and Ac-RASQNYPVV-NH2 peaks was found to be linear for up to 20 min (37°C, <20o conversion to product), and initial rates were determined for samples in which product formation had not exceeded 15%. From a double reciprocal plot ofthe initial rates at various Ac-RASQNYPVV-NH2 concentrations (1-15 mM), the kinetic constants Km = 5.5 + 0.3 mM and Vma,, = 1.59 ± 0.04 nmol/ min (8 ng of protease) were obtained (37°C, pH 6.0) by fitting the data to Eq. 1. If it is assumed that HIV-1 protease contains one active site per 22-kDa dimer (see below), the resulting kcat and kcat/Km values for this substrate and enzyme preparation would be 70 sec-1 and 13 mM-'sec-1, respectively. Native Molecular Mass of the Protease Suggests a Dimeric Structure. As suggested by structural modeling of their primary sequences, the retroviral proteases would most resemble the structure of the aspartic proteases if they existed as protein dimers (17). To investigate this model, we sought to compare the molecular mass of HIV-1 protease obtained under nondenaturing conditions with the value of 11 kDa found upon NaDodSO4/PAGE analysis of the purified enzyme. Analytical gel filtration of PRO4 extract on Sephacryl S-200 demonstrated that HIV-1 protease activity eluted in a sharp peak (74.7-76.0 ml) prior to the protein standard myoglobin, consistent with an apparent native molecular mass of 18-19 kDa (Fig. 3A) . That the native molecular mass obtained from gel filtration is nearly twice that of the denatured protein has also been reported for the retroviral protease from Moloney murine leukemia virus (31). The Stokes radius of the protease (a = 2.0 + 0.2 nm) was determined from these data by the method of Laurent and Killander (32) .
From glycerol density gradient ultracentrifugation of the purified protease, the enzyme activity sedimented at a distance consistent with that of a 21-kDa protein (Fig. 3B) , yielding a sedimentation coefficient of 2.4 ± 0.1 S (average of three determinations). This observed sedimentation coefficient was invariant in the presence or absence of Triton X-100. The molecular weight (M) of the protease was calculated from the sedimentation coefficient (s -2.4 x 10-13 sec), the Stokes radius (a = 2.0 x 10-7 cm), and the calculated partial specific volume [v = 0.757 cm3/g (33) ] by using the equation of Siegel and Monty (34) : M = 61rnasN/(1 -vp), in which r1 and p are, respectively, the viscosity and density of water at 20°C and N is Avogadro's number. From this, the molecular weight of the native HIV-1 protease was determined to be 22,000 ± 3000, a value twice that expected from the amino acid composition. These findings strongly suggest that the active form of HIV-1 protease is a dimer of identical 11-kDa subunits.
Oligomeric protein structures have also been detected by chemical crosslinking as evidenced by NaDodSO4/PAGE (27). Purified HIV-1 protease was crosslinked at pH 8.5 by the amine-specific reagent DMS in large excess. An immunoreactive 22-kDa protein band approximately equal in intensity to the monomeric protease (11 kDa) was visible The protein standards used were cytochrome c (12.5 kDa, 1.9 S), chymotrypsinogen A (25 kDa, 2.7 S), and ovalbumin (44 kDa, 3.5 S). HIV-1 protease was assayed by the peptidolytic assay. Relative mobility (Fr) = peak fraction (from bottom of tube)/total fractions (from bottom of tube).
upon immunoblot analysis (Fig. 4) . Although larger oligomeric forms were apparent at the highest concentrations of protease used (10 pg), the observation of both 22-kDa and 11-kDa species over a 100-fold concentration range of the protein is in accord with an "intramolecular" reaction between the subunits of a protein dimer.
Inactivators of Aspartic Proteases Inactivate HIV-1 Protease., The activity of the enzyme was measured following pretreatment with a number of protease inactivators. At high concentrations (0.1 mM and 10 mM), none of the inactivators of the serine proteases [phenylmethylsulfonyl fluoride, benzamidine, N-tosyl-L-phenylethyl chloromethyl ketone, soybean trypsin inhibitor (0.2 mg/ml), leupeptin (2.2 mg/ml)] or of the metalloproteases (1, EDTA, phoramidon) effected significant inactivation of the peptidolytic activity of HIV-1 protease. In contrast, the sulfhydrylspecific reagents N-ethylmaleimide and iodoacetamide inactivated the enzyme to <10% of its initial activity at concentrations of 0.1 mM, suggesting that a cysteine residue is important to its catalytic activity or its structure. Inactivators of the aspartic proteases each effected some or significant loss of protease activity. Pretreatment of the enzyme with 0.1 mM pepstatin A, 10 mM EPNP, and 10 mM N-diazoacetylnorleucine ethyl ester (0.1 mM cupric ion) resulted in >50% inactivation of protease activity. These findings are similar to those reported for the retroviral proteases from avian myeloblastosis virus (35) and bovine leukemia virus (36) .
EPNP has been shown by protein sequencing and by x-ray crystallographic analysis to esterify one or both of the active site aspartic residues of pepsin (37-39). In our hands, increasing concentrations of EPNP effected time-dependent inactivation of HIV-1 protease (Fig. SA) (Fig. 5B) . The rate of protease inactivation was diminished upon protonation of an enzymic residue of pK = 3.8 ± 0.09, suggesting that the epoxide esterifies an unprotonated carboxylic residue. The inactivation of the protease at pH 6.0 by samples of EPNP pretreated at pH 3-6 was invariant (Fig. 5B) , indicating that the decrease in inactivation observed at lower pH values is not due to acid-catalyzed hydrolysis of the epoxide. Furthermore, kinetic plots of log Vmax and log Vmax/Km vs. pH (pH 2-6; Ac-RASQNYPVV-NH2 as substrate) are both characterized by decreasing values below pH 4 (pKa = 3.6 and 3.4, respectively), which also implicates the involvement of an unprotonated carboxylic residue in the catalytic mechanism. In view of the sequence homology to the aspartic proteases, we propose from our mechanistic studies that the HIV-1 protease also belongs to this class of proteases. This proposal is supported by two recent studies in which the site-specific mutation of the aspartic residue within the conserved AspThr-Gly sequence of the HIV-1 protease (expressed in E. colt) to an asparagine (10) 
